BIO Leads Letter to Congressional Appropriations Committees for FDA Funding on Plant Biotech
April 19, 2022
The farmers, cooperatives, researchers, retailers, seed producers, scientists, and technology developers represented by the organizations below write to express our strong support for the inclusion of language in the Fiscal Year 2023 (FY 2023) Agriculture, Rural Development, Food, and Drug Administration, and Related Agencies (Agriculture) Appropriations bill to provide the U.S. Food and Drug Administration (FDA) the necessary resources to develop and publish for public comment its draft guidance on how its regulatory policy for foods derived from new plant varieties applies to foods from plants produced using genome editing.
BIO and the American Seed Trade Association submitted comments on USDA-APHIS' proposed exemptions of five types of genetic modifications a plant can contain and be exempt from regulations for the movement of organisms modified or produced through…
BIO joined with other groups in writing House and Senate Agriculture Committee leaders in support of agricultural research (FFAR) funding in the farm bill.
BIO and 59 other organizations have written to House and Senate Agriculture Committee leaders to ask that they direct Congress to withdraw the current rule concerning regulation of plant incorporated protectants and replace it one based on a science…
The farmers, cooperatives, researchers, retailers, seed producers, scientists, and technology developers represented by the organizations below write to express our strong support for the inclusion of language in the Fiscal Year 2023 (FY 2023) Agriculture, Rural Development, Food, and Drug Administration, and Related Agencies (Agriculture) Appropriations bill to provide the U.S. Food and Drug Administration (FDA) the necessary resources to develop and publish for public comment its draft guidance on how its regulatory policy for foods derived from new plant varieties applies to foods from plants produced using genome editing.